137 related articles for article (PubMed ID: 3416271)
1. Immunosuppressive substance in the sera of head and neck cancer patients.
Yamanaka N; Harabuchi Y; Himi T; Kataura A
Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of immunosuppressive factors (IAP-immunosuppressive acidic protein, IS-immunosuppressive substance) in head and neck cancer].
Saito T; Dake Y; Kakiuti H; Kato Y; Kuki K; Hayashi Y; Yokota M; Kinoshita K; Kuki S; Kimura T
Nihon Jibiinkoka Gakkai Kaiho; 1989 Apr; 92(4):588-96. PubMed ID: 2769476
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the serum level of immunosuppressive substance in oral cancer patients.
Kubota E; Kurokawa H; Katsuki T
J Oral Maxillofac Surg; 1991 Feb; 49(2):121-6. PubMed ID: 1990088
[TBL] [Abstract][Full Text] [Related]
5. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1993 Oct; 72(4):409-12. PubMed ID: 8261296
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
9. Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients.
Nakashima T; Tanaka M; Okamura S
J Laryngol Otol; 1991 Nov; 105(11):939-45. PubMed ID: 1761949
[TBL] [Abstract][Full Text] [Related]
10. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunosuppressive acidic protein in human ovarian cancer.
Lin YH; Chow SN; Chen CK; Chen RJ; Huang SC; Huang GT
J Formos Med Assoc; 1994 Sep; 93(9):776-80. PubMed ID: 7735007
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive acidic protein in patients with gynecologic cancer.
Sawada M; Okudaira Y; Matsui Y; Shimizu Y
Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive acidic protein in patients with ovarian cancer.
Sawada M; Okudaira Y; Matsui Y; Shimizu Y
Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
[TBL] [Abstract][Full Text] [Related]
16. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
18. Serum immunosuppressive acidic protein levels in blackfoot disease patients and cancer patients.
Lu FJ; Chang KJ; Chen BH; Liaw FR; Liau SR; Chen HY
J Formos Med Assoc; 1990 Apr; 89(4):255-8. PubMed ID: 1976740
[TBL] [Abstract][Full Text] [Related]
19. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]